Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-03-16 Purchase | 2023-06-08 9:35 pm | Marker Therapeutics Inc. | MRKR | Eansor Norman David Director | 14,285 | $17.5 | $249,988 | 17,570 (Indirect Direct) | View |
| 2021-05-18 Purchase | 2021-05-20 4:32 pm | Marker Therapeutics Inc. | MRKR | Wasserman Frederick Gerald Director | 10,000 | $2.4098 | $24,098 | 52,565 (Direct) | View |
| 2021-03-16 Purchase | 2021-03-18 5:18 pm | Marker Therapeutics Inc. | MRKR | Walker Paul Edward 10% Owner | 5,714,285 | $1.75 | $9,999,999 | 10,714,285 (Indirect) | View |
| 2021-03-16 Purchase | 2021-03-18 5:17 pm | Marker Therapeutics Inc. | MRKR | Sonsini Peter W. 10% Owner | 5,714,285 | $1.75 | $9,999,999 | 10,714,285 (Indirect) | View |
| 2021-03-16 Purchase | 2021-03-18 5:17 pm | Marker Therapeutics Inc. | MRKR | SANDELL SCOTT D 10% Owner | 5,714,285 | $1.75 | $9,999,999 | 10,714,285 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-06 Option Award | 2023-06-08 9:35 pm | N/A 2033-06-05 | Marker Therapeutics Inc. | MRKR | Eansor Norman David Director | 8,000 | $0 | 17,570 (Direct) | View |
| 2021-03-25 Gift | 2023-06-08 9:35 pm | N/A N/A | Marker Therapeutics Inc. | MRKR | Eansor Norman David Director | 21,427 | $0 | 17,570 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 9:34 pm | N/A 2033-06-05 | Marker Therapeutics Inc. | MRKR | Knobil Katharine Director | 8,000 | $0 | 8,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 9:33 pm | N/A 2033-06-05 | Marker Therapeutics Inc. | MRKR | Wilson John Robert Director | 8,000 | $0 | 8,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 9:32 pm | N/A 2033-06-05 | Marker Therapeutics Inc. | MRKR | ELMS STEVE Director | 8,000 | $0 | 8,000 (Direct) | View |
| 2023-05-10 Option Award | 2023-05-11 6:10 pm | N/A 2033-05-10 | Marker Therapeutics Inc. | MRKR | Vera Juan President and CEO | 100,000 | $0 | 100,000 (Direct) | View |
| 2023-02-27 Option Award | 2023-03-01 4:52 pm | N/A 2033-02-27 | Marker Therapeutics Inc. | MRKR | Hoang Tsvetelina P VP, Research and Development | 33,159 | $0 | 33,159 (Direct) | View |
| 2023-02-27 Option Award | 2023-03-01 4:51 pm | N/A 2033-02-27 | Marker Therapeutics Inc. | MRKR | Koneru Mythili Chief Medical Officer | 51,918 | $0 | 51,918 (Direct) | View |
| 2023-02-27 Option Award | 2023-03-01 4:50 pm | N/A 2033-02-27 | Marker Therapeutics Inc. | MRKR | Loiacono Michael Chief Accounting Officer | 38,480 | $0 | 38,480 (Direct) | View |
| 2023-02-27 Option Award | 2023-03-01 4:49 pm | N/A 2033-02-27 | Marker Therapeutics Inc. | MRKR | Vera Juan Chief Scientific Officer & COO | 46,487 | $0 | 46,487 (Direct) | View |
| 2023-02-27 Option Award | 2023-03-01 4:48 pm | N/A 2033-02-27 | Marker Therapeutics Inc. | MRKR | Szymanska Anna Vice President, Quality | 29,947 | $0 | 29,947 (Direct) | View |
| 2023-02-27 Option Award | 2023-03-01 4:47 pm | N/A 2033-02-27 | Marker Therapeutics Inc. | MRKR | Agopyan Nadia SVP, Regulatory Affairs | 34,154 | $0 | 34,154 (Direct) | View |
| 2022-05-24 Option Award | 2022-05-26 4:12 pm | N/A 2032-05-23 | Marker Therapeutics Inc. | MRKR | Wilson John Robert Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2022-05-24 Option Award | 2022-05-26 4:10 pm | N/A 2032-05-23 | Marker Therapeutics Inc. | MRKR | Laskow-Pooley David Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2022-05-24 Option Award | 2022-05-26 4:10 pm | N/A 2032-05-23 | Marker Therapeutics Inc. | MRKR | Knobil Katharine Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2022-05-24 Option Award | 2022-05-26 4:09 pm | N/A 2032-05-23 | Marker Therapeutics Inc. | MRKR | ELMS STEVE Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2022-05-24 Option Award | 2022-05-26 4:08 pm | N/A 2032-05-23 | Marker Therapeutics Inc. | MRKR | Eansor Norman David Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2022-03-24 Tax Withholding | 2022-03-28 9:06 pm | N/A N/A | Marker Therapeutics Inc. | MRKR | Hoang Peter L. President and CEO | 48,376 | $0.4848 | 483,286 (Direct) | View |
| 2022-03-24 Option Award | 2022-03-28 9:06 pm | N/A N/A | Marker Therapeutics Inc. | MRKR | Hoang Peter L. President and CEO | 199,094 | $0 | 483,286 (Direct) | View |
| 2022-03-24 Tax Withholding | 2022-03-28 9:04 pm | N/A N/A | Marker Therapeutics Inc. | MRKR | Vera Juan Chief Scientific Officer & COO | 33,465 | $0.4848 | 2,671,845 (Direct) | View |
| 2022-03-24 Option Award | 2022-03-28 9:04 pm | N/A N/A | Marker Therapeutics Inc. | MRKR | Vera Juan Chief Scientific Officer & COO | 140,823 | $0 | 2,671,845 (Direct) | View |
| 2022-03-24 Tax Withholding | 2022-03-28 9:03 pm | N/A N/A | Marker Therapeutics Inc. | MRKR | Kim Anthony H. Chief Financial Officer | 36,076 | $0.4848 | 114,436 (Direct) | View |
| 2022-03-24 Option Award | 2022-03-28 9:03 pm | N/A N/A | Marker Therapeutics Inc. | MRKR | Kim Anthony H. Chief Financial Officer | 150,512 | $0 | 114,436 (Direct) | View |
| 2022-02-17 Option Award | 2022-02-22 5:14 pm | N/A 2032-02-17 | Marker Therapeutics Inc. | MRKR | Hoang Peter L. President and CEO | 430,000 | $0 | 430,000 (Direct) | View |
| 2022-02-17 Option Award | 2022-02-22 5:12 pm | N/A 2032-02-17 | Marker Therapeutics Inc. | MRKR | Vera Juan Chief Scientific Officer & COO | 160,000 | $0 | 160,000 (Direct) | View |
| 2022-02-17 Option Award | 2022-02-22 5:10 pm | N/A 2032-02-17 | Marker Therapeutics Inc. | MRKR | Szymanska Anna Vice President, Quality | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-02-17 Option Award | 2022-02-22 5:09 pm | N/A 2032-02-17 | Marker Therapeutics Inc. | MRKR | Loiacono Michael Chief Accounting Officer | 140,000 | $0 | 140,000 (Direct) | View |
| 2022-02-17 Option Award | 2022-02-22 5:07 pm | N/A 2032-02-17 | Marker Therapeutics Inc. | MRKR | Koneru Mythili Chief Medical Officer | 160,000 | $0 | 160,000 (Direct) | View |
| 2022-02-17 Option Award | 2022-02-22 5:06 pm | N/A 2032-02-17 | Marker Therapeutics Inc. | MRKR | Kim Anthony H. Chief Financial Officer | 160,000 | $0 | 160,000 (Direct) | View |
| 2022-02-17 Option Award | 2022-02-22 5:04 pm | N/A 2032-02-17 | Marker Therapeutics Inc. | MRKR | Hoang Tsvetelina P VP, Research and Development | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-02-17 Option Award | 2022-02-22 5:02 pm | N/A 2032-02-17 | Marker Therapeutics Inc. | MRKR | Garrett Gerald Vice President, Clinical Ops. | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-02-17 Option Award | 2022-02-22 5:01 pm | N/A 2032-02-17 | Marker Therapeutics Inc. | MRKR | Agopyan Nadia VP, Regulatory Affairs | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-12-08 Option Award | 2021-12-09 5:20 pm | N/A 2031-12-07 | Marker Therapeutics Inc. | MRKR | Knobil Katharine Director | 125,000 | $0 | 125,000 (Direct) | View |
Ownership | 2021-12-09 5:18 pm | N/A N/A | Marker Therapeutics Inc. | MRKR | Knobil Katharine Director | 0 | $0 | 1,500 (Indirect) | View |
| 2021-06-08 Option Award | 2021-06-10 6:57 pm | N/A N/A | Marker Therapeutics Inc. | MRKR | Wasserman Frederick Gerald Director | 12,658 | $0 | 65,223 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-10 6:56 pm | N/A N/A | Marker Therapeutics Inc. | MRKR | Laskow-Pooley David Director | 12,658 | $0 | 55,223 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-10 6:55 pm | N/A N/A | Marker Therapeutics Inc. | MRKR | ELMS STEVE Director | 12,658 | $0 | 3,172,537 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-10 6:54 pm | N/A N/A | Marker Therapeutics Inc. | MRKR | Eansor Norman David Director | 12,658 | $0 | 36,940 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-10 6:53 pm | N/A N/A | Marker Therapeutics Inc. | MRKR | Wilson John Robert Director | 12,658 | $0 | 7,812,008 (Direct) | View |